Catherine Skari

Corporate Reputation of Pharma Companies for 2018 – The Patients’ Perspective

What did 1,500 patient groups from different countries and therapy areas think of pharmaceutical companies in 2018? To what extent…

Read More »

Gene Therapy for β-Thalassaemia Approaches European Market Approval

Gene therapy continues to evolve with new emerging treatments finally reaching its promised potential: providing a one-time lifelong cure for…

Read More »

World Hemophilia Day 2019

World Hemophilia Day is an international awareness day for hemophilia and other bleeding disorders. It is held annually on April…

Read More »

TIF held its 1st Board of Directors Meeting for 2019 in Fujairah, UAE

Read More »

TIF Signs Agreement With Resonance Health To Deploy FerriSmart®

FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under…

Read More »

La Repubblica: Gene Editing Cured Two Siblings With Thalassaemia In Italy

Cured of thalassemia, thanks to gene editing. According to a recent news report published in the Italian newspaper La Repubblica,…

Read More »

Delegation Visit to France – 1 February 2019

Read More »

TIF leads the way in creating a Community Advisory Board (CAB) in Europe for thalassaemia and sickle cell disease

  ANNOUNCEMENT:   Dear friends and esteemed collaborators, The Thalassaemia International Federation (TIF) since its establishment in 1986 has been…

Read More »

Egypt celebrates the ITD 2019 with an International Scientific Conference in Cairo

The Egyptian Thalassaemia Association (ETA),  in celebration of this year’s International Thalassaemia Day, is organizing the 20th International Thalassaemia Day…

Read More »

From labs to shelves: EMA’s new booklet explains how drugs are developed and marketed in the EU

  The European Medicines Agency (EMA) has published a booklet describing the journey of a medicine for human use authorised…

Read More »